Intro

This chapter examines 23andMe's recent bankruptcy filing, analyzing its implications for the company's future and the genetic testing industry. The discussion highlights the operational challenges and industry shifts that could reshape the biotechnology sector.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app